Patent directory Β· USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code β or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 7175981
Method of diagnosing stage or aggressiveness of breast and prostate cancer based on levels of fatty acid binding proteins
granted -
US 7175848
Ricin A chain mutants lacking enzymatic activity as vaccines to protect against aerosolized ricin
granted -
US 7175845
Monoclonal antibodies against ricin toxin and methods of making and using thereof
granted -
US 7175838
Use of a promoter of T-cell expansion and an inducer of CD40 stimulation in the treatment or prevention of a pathologic state
granted -
US 7175843
Methods for selectively stimulating proliferation of T cells
granted -
US 7175830
Imaging of drug accumulation as a guide to antitumor therapy
granted -
US 7176280
Isolated polypeptides and compositions from the venom of P. transvaalicus and methods of use
granted -
US 7176233
Salinosporamides and methods for use thereof
granted -
US 7176302
Liposomal phosphodiester, phosphorothioate, and p-ethoxy oligonucleotides
granted -
US 7176232
Salinosporamides and methods for use thereof
granted -
US 7176244
Use of 2-nitropropanol, 2-nitroethane, and 2-nitroethanol for control of microbial pathogens
granted -
US 7176211
Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
granted -
US 7176201
Modulation of anxiety through blockade of anandamide hydrolysis
granted -
US 7176179
Selective induction of cell death by delivery of amino-terminal interleukin-1-Ξ± pro-piece polypeptide
granted -
US 7176283
Protease-activated receptor 3 and uses thereof
granted -
US 7172869
Methods for transfecting T cells
granted -
US 7173027
Receptor selective cannabimimetic aminoalkylindoles
granted -
US 7173039
Protein kinase inhibitors
granted -
US 7173112
Antibody to GALP and uses thereof
granted -
US 7173062
Method for the improvement of skin wrinkles using retinyl retinoate
granted -
US 7173007
Therapy for microbial infections
granted -
US 7173005
Insulin and IGF-1 receptor agonists and antagonists
granted -
US 7172876
Method of screening therapeutic agents for nerve degeneration associated diseases
granted -
US 7172770
Mesoporous compositions for use in drug delivery
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search β best for looking up a specific filing or applicant portfolio slice.